Dashboard
Manage Tickers

SNPX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
TAO Synergies, Formerly Synaptogenix, Begi...
07/01/2025 13:23:11

New name and stock symbol highlight strategic commitment to TAO, the leading AIcryptocurrencyNEW YORK, July 1, 2025 /PRNewswire...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
06/27/2025 21:05:51

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
06/26/2025 17:05:57

synaptogenix-changes-name-to-tao-synergies-to-begin-trading-on-nasdaq-under-new-ticker-symbol-taox-on-july-1-2025
Synaptogenix Changes Name To TAO Synergies...
06/26/2025 13:18:17

New trading symbol "TAOX" effective Tuesday, July 1, 2025,New name represents Company's strategic focus on the syne...

synaptogenix-announces-initial-purchase-of-tao-as-part-of-cryptocurrency-treasury-strategy-focused-exclusively-on-al-and-machine-learning-selects-bitgo-as-custodian
Synaptogenix Announces Initial Purchase Of...
06/24/2025 13:18:21

Strategic capital deployment into TAO advances Synaptogenix's blockchain treasury model, leveraging BitGo's custody, tr...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/17/2025 12:08:52

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
06/09/2025 17:06:06

synaptogenix-launches-100m-ai-token-treasury-strategy-focused-on-bittensor-tao-with-10m-initial-acquisition-led-by-crypto-expert-james-altucher
Synaptogenix Launches $100M AI Token Treas...
06/09/2025 13:09:40

Singular focus on Bittensor (TAO), the leading AI token byadoption and market capitalizationJames Altucher to lead TAO token st...

synaptogenix-names-james-altucher-to-lead-digital-asset-treasury-strategy
Synaptogenix Names James Altucher To Lead ...
06/09/2025 13:04:41

synaptogenix-q1-eps-004-up-from-041-yoy
Synaptogenix Q1 EPS $0.04 Up From $(0.41) YoY
05/15/2025 21:52:04

Synaptogenix (NASDAQ:SNPX) reported quarterly earnings of $0.04 per share. This is a 109.76 percent increase over losses of $(0...

synaptogenix-board-of-directors-forms-special-committee-to-explore-value-creation-opportunities
Synaptogenix Board Of Directors Forms Spec...
12/20/2024 14:20:09

$19.6 million in cash and cash equivalents as of September 30, 2024Dramatically reduced cash burn rate expected

synaptogenix-enters-into-securities-purchase-agreements-for-a-5m-financing-with-existing-investors-involving-the-sale-of-5000-shares-of-its-newly-issued-series-c-convertible-preferred-stock-with-a-stated-value-of-1000-per-share-the-shares-of-series-c-preferred-stock-have-an-initial-conversion-price-of-400-per-share-and-accrue-a-50-quarterly-dividend-payable-in-cash
Synaptogenix Enters Into Securities Purcha...
09/11/2024 13:07:41

Synaptogenix, Inc. (NASDAQ:SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company devel...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
09/02/2024 12:05:52

synaptogenix-announces-collaboration-with-lsu-health-new-orleans-for-pre-clinical-testing-of-pufa-analogs-for-spinal-cord-injury
Synaptogenix Announces Collaboration With ...
07/18/2024 13:05:50

New Patent Issued Covering Treatment Of Neurodegenerative Diseases; Studies To Compare Analogs With Bryostatin In SCI

maxim-group-upgrades-synaptogenix-to-buy-announces-14-price-target
Maxim Group Upgrades Synaptogenix to Buy, ...
07/11/2024 13:08:42

Maxim Group analyst Jason McCarthy upgrades Synaptogenix (NASDAQ:SNPX) from Hold to Buy and announces $14 price target.

synaptogenix-announces-fda-authorization-of-its-investigational-new-drug-application-for-bryostatin-1-trial-in-multiple-sclerosis
Synaptogenix Announces FDA Authorization O...
06/26/2024 13:13:28

synaptogenix-has-been-granted-us-patent-number-12016837-titled-halogenated-esters-of-cyclopropanated-unsaturated-fatty-acids-for-use-in-the-treatment-of-neurodegenerative-diseases-including-alzheimers-disease
Synaptogenix Has Been Granted U.S. Patent ...
06/25/2024 15:46:53

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12016837).pn

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/10/2024 20:31:10

synaptogenix-regains-compliance-with-nasdaq-minimum-bid-price-requirement-for-continued-listing
Synaptogenix Regains Compliance With Nasda...
04/24/2024 13:17:41

Synaptogenix, Inc. (NASDAQ:SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company devel...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/10/2024 12:09:34

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION